Abstract: An array of antiperspirant products, comprising a first antiperspirant product that is marketed to male consumers and marketed as clinical strength or prescription strength; and a second antiperspirant product that is marketed to female consumers and marketed as clinical strength or prescription strength.

Abstract: An array of antiperspirant products, comprising a first antiperspirant product that is marketed to male consumers and marketed as clinical strength or prescription strength; and a second antiperspirant product that is marketed to female consumers and marketed as clinical strength or prescription strength.

Abstract: A line of consumer products having two or more product performance characteristics, said line comprising: (a) a first product comprising at least one antiperspirant and a first identifier; and (b) a second product comprising at least one antiperspirant that is different from said first product and wherein said second product is absent aluminum chloride, said second product also comprising at least one second identifier wherein the at least one second identifier also communicates to the consumer prescription strength.

Abstract: An array of antiperspirant products including a first antiperspirant product sold under a first brand name, a second antiperspirant product also sold under the first brand name, wherein the second antiperspirant product is marketed as clinical strength or prescription strength and is substantially devoid of an antiperspirant active comprising aluminum chloride.

Abstract: Antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (c) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (d) from about 5 ppm to about 20% by weight of the composition, of a primary fragrance; and (e) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix substantially odorless prior to aqueous activation, wherein the antiperspirant composition is substantially devoid of a malodor reducing agent.

Abstract: Anhydrous, solid antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (c) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (d) from about 5 ppm to about 20% by weight of the composition, of a primary fragrance; and (e) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix substantially odorless prior to aqueous activation, wherein the anhydrous, solid antiperspirant composition exhibits an Antiperspirant Efficacy Index of at least about 0.9, and wherein the anhydrous, solid antiperspirant composition is substantially devoid of a malodor reducing agent.

Abstract: A line of consumer products having two or more product performance characteristic, said line comprising: (a) a first product comprising at least one non-prescription strength antiperspirant and a first identifier; and (b) a second product comprising at least one prescription strength antiperspirant and a second identifier wherein said first identifier and said second identifier are different.

Abstract: Antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.05% to about 15% by weight of the composition, of a malodor reducing agent; (c) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (d) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (e) from about 0% to about 20% by weight of the composition, of a primary fragrance; and (f) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix initially substantially odorless.

Abstract: A line of personal care products comprising a first product comprising a first identifier and a second product comprising a second identifier wherein said first identifier and said second identifier are synergistic wherein said first identifier and said second identifier together communicate that said first product and said second product should be bought and used in relation to each other.

Abstract: Antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.05% to about 15% by weight of the composition, of a malodor reducing agent; (c) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (d) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (e) from about 5 ppm to about 20% by weight of the composition, of a primary fragrance; and (f) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix substantially odorless prior to aqueous activation.

Abstract: Anhydrous, solid antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.05% to about 15% by weight of the composition, of a malodor reducing agent; (c) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (d) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (e) from about 0% to about 20% by weight of the composition, of a primary fragrance; and (f) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix initially substantially odorless wherein the anhydrous, solid antiperspirant composition exhibits an Antiperspirant Efficacy Index of at least about 0.9.

Abstract: Anhydrous, solid antiperspirant compositions comprising: (a) from about 0.1% to about 30% by weight of the composition, of a high-efficacy antiperspirant active; (b) from about 0.05% to about 15% by weight of the composition, of a malodor reducing agent; (c) from about 0.1% to about 35% by weight of the composition, of a thickening agent; (d) from about 10% to about 99% by weight of the composition, of an anhydrous liquid carrier; (e) from about 5 ppm to about 20% by weight of the composition, of a primary fragrance; and (f) from at least about 5 ppm by weight of the composition, of a secondary fragrance that is distinct from the primary fragrance and is included in a surfactant-free, water-releasable matrix, which renders the secondary fragrance within the matrix substantially odorless prior to aqueous activation and wherein the anhydrous, solid antiperspirant composition exhibits an Antiperspirant Efficacy Index of at least about 0.9.

Abstract: A beta prime stable plastic shortening exhibiting superior baking and frying performance and containing reduced levels of saturates and trans fatty acids is disclosed. The shortening is particularly useful in confectionery, baking, and frying applications. The plastic shortening of the present invention comprises from about 6% to about 25% by volume, of an inert gas and from about 75% to about 94% by volume of a fat phase comprising:a) from about 74% to about 90% by weight of a base oil having less than 10% by weight of trans fatty acids, less than 16% C.sub.4 -C.sub.26 fatty acids,b) from about 10% to about 20% by weight of a beta prime stable crystalline hardstock consisting essentially of at least 65% of PSP and PSS, wherein the ratio of PSP:PSS is at least 0.8 to 1.

Abstract: Deaerated oil having a level of less than about 0.10% by volume of dissolved oxygen is heated at a temperature between about 530.degree. F. (277.degree. C.) and about 650.degree. F. (343.degree. C.) and stripped with a stripping medium with a molar ratio of stripping medium to oil of between about 0.05 and about 9.7, at an absolute pressure of between about 0.5 mm Hg and about 50 mm Hg., for a time of between about 5 seconds and about 15 minutes. The combination of stripping parameters is selected so that the stripping factor "f" is greater than about 0.6, where f=KP.sub.v S/PO, where K is between about 1 and about 200, and where P.sub.v (the vapor pressure of the component to be stripped) is not more than about 0.1 mm Hg at 500.degree. F. (277.degree. C.) and not more than about 2.0 mm Hg at 600.degree. F. (343.degree. C.).